<?xml version="1.0" encoding="UTF-8"?>
<collection>
<dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:invenio="http://invenio-software.org/elements/1.0" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd"><dc:identifier>doi:10.3390/ijms21197331</dc:identifier><dc:language>eng</dc:language><dc:creator>Abuobeid, R.</dc:creator><dc:creator>Herrera-Marcos, L.</dc:creator><dc:creator>Navarro, M.A.</dc:creator><dc:creator>Arnal, C.</dc:creator><dc:creator>Martínez-Beamonte, R.</dc:creator><dc:creator>Surra, J.</dc:creator><dc:creator>Osada, J.</dc:creator><dc:title>Dietary erythrodiol modifies hepatic transcriptome in mice in a sex and dose-dependent way</dc:title><dc:identifier>ART-2020-120761</dc:identifier><dc:description>Erythrodiol is a terpenic compound found in a large number of plants. To test the hypotheses that its long-term administration may influence hepatic transcriptome and this could be influenced by the presence of APOA1-containing high-density lipoproteins (HDL), Western diets containing 0.01% of erythrodiol (10 mg/kg dose) were provided to Apoe-and Apoa1-deficient mice. Hepatic RNA-sequencing was carried out in male Apoe-deficient mice fed purified Western diets differing in the erythrodiol content. The administration of this compound significantly up-regulated 68 and down-regulated 124 genes at the level of 2-fold change. These genes belonged to detoxification processes, protein metabolism and nucleic acid related metabolites. Gene expression changes of 21 selected transcripts were verified by RT-qPCR. Ccl19-ps2, Cyp2b10, Rbm14-rbm4, Sec61g, Tmem81, Prtn3, Amy2a5, Cyp2b9 and Mup1 showed significant changes by erythrodiol administration. When Cyp2b10, Dmbt1, Cyp2b13, Prtn3 and Cyp2b9 were analyzed in female Apoe-deficient mice, no change was observed. Likewise, no significant variation was observed in Apoa1-or in Apoe-deficient mice receiving doses ranging from 0.5 to 5 mg/kg erythrodiol. Our results give evidence that erythrodiol exerts a hepatic transcriptional role, but this is selective in terms of sex and requires a threshold dose. Furthermore, it requires an APOA1-containing HDL.</dc:description><dc:date>2020</dc:date><dc:source>http://zaguan.unizar.es/record/96115</dc:source><dc:doi>10.3390/ijms21197331</dc:doi><dc:identifier>http://zaguan.unizar.es/record/96115</dc:identifier><dc:identifier>oai:zaguan.unizar.es:96115</dc:identifier><dc:relation>info:eu-repo/grantAgreement/ES/CIBERObn/CB06-03-1012</dc:relation><dc:relation>info:eu-repo/grantAgreement/ES/DGA/FSE</dc:relation><dc:relation>info:eu-repo/grantAgreement/ES/DGA-FSE/B16-20R</dc:relation><dc:relation>info:eu-repo/grantAgreement/ES/MICINN-ISCIIII-FEDER/PID2019-104915RB-I00</dc:relation><dc:relation>info:eu-repo/grantAgreement/ES/MINECO/SAF2016-75441-R</dc:relation><dc:identifier.citation>International Journal of Molecular Sciences 21, 19 (2020), 7331 [21 pp]</dc:identifier.citation><dc:rights>by</dc:rights><dc:rights>http://creativecommons.org/licenses/by/3.0/es/</dc:rights><dc:rights>info:eu-repo/semantics/openAccess</dc:rights></dc:dc>

</collection>